News
GOVXW
0.0266
-33.67%
-0.0135
Weekly Report: what happened at GOVXW last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at GOVXW last week (0311-0315)?
Weekly Report · 03/18 09:53
Geovax Labs Inc: Notice of Effectiveness
Press release · 03/11 12:00
Weekly Report: what happened at GOVXW last week (0304-0308)?
Weekly Report · 03/11 09:52
Weekly Report: what happened at GOVXW last week (0226-0301)?
Weekly Report · 03/04 09:54
Weekly Report: what happened at GOVXW last week (0219-0223)?
Weekly Report · 02/26 09:59
Weekly Report: what happened at GOVXW last week (0212-0216)?
Weekly Report · 02/19 09:59
GeoVax to Present at the 2024 BIO CEO & Investor Conference
GeoVax Labs, Inc. Is a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases. Chairman and CEO David Dodd will present at the 2024 BIO CEO & Investor Conference in New York, NY on February 26-27, 2024.
Barchart · 02/19 08:00
Weekly Report: what happened at GOVXW last week (0205-0209)?
Weekly Report · 02/12 09:55
Weekly Report: what happened at GOVXW last week (0129-0202)?
Weekly Report · 02/05 09:58
Weekly Report: what happened at GOVXW last week (0122-0126)?
Weekly Report · 01/29 09:54
Weekly Report: what happened at GOVXW last week (0115-0119)?
Weekly Report · 01/22 09:56
Geovax Labs Inc: Current report
Press release · 01/17 00:00
Weekly Report: what happened at GOVXW last week (0108-0112)?
Weekly Report · 01/15 09:54
Geovax Labs Inc: Prospectus [Rule 424(b)(3)]
Press release · 01/12 22:00
Geovax Labs Inc: Notice of Effectiveness
Press release · 01/12 12:00
Weekly Report: what happened at GOVXW last week (0101-0105)?
Weekly Report · 01/08 09:56
Geovax Labs Inc: General form for registration of securities under the Securities Act of 1933
Press release · 01/02 22:00
Weekly Report: what happened at GOVXW last week (1225-1229)?
Weekly Report · 01/01 09:53
Geovax Labs Inc: Statement of changes in beneficial ownership of securities
Press release · 12/27/2023 02:00
More
Webull provides a variety of real-time GOVXW stock news. You can receive the latest news about Geovax Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About GOVXW
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.